Annual CAPEX
$210.00 K
-$5.53 M-96.34%
30 June 2024
Summary:
iBio annual capital expenditures is currently $210.00 thousand, with the most recent change of -$5.53 million (-96.34%) on 30 June 2024. During the last 3 years, it has fallen by -$4.95 million (-95.93%). IBIO annual CAPEX is now -98.19% below its all-time high of $11.63 million, reached on 30 June 2022.IBIO CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2024
Summary:
iBio quarterly capital expenditures is not available.IBIO Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2024
Summary:
iBio TTM capital expenditures is not available.IBIO TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IBIO CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -96.3% | - | - |
| 3 y3 years | -95.9% | - | - |
| 5 y5 years | -78.8% | - | - |
IBIO CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -98.2% | at low | ||||
| 5 y | 5 years | -98.2% | at low | ||||
| alltime | all time | -98.2% | +208.8% |
IBio CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | $210.00 K(-96.3%) | - | - |
| June 2023 | $5.74 M(-50.7%) | $506.00 K(-351.7%) | $5.74 M(-33.8%) |
| Mar 2023 | - | -$201.00 K(-106.8%) | $8.66 M(-20.8%) |
| Dec 2022 | - | $2.95 M(+19.2%) | $10.94 M(+8.1%) |
| Sept 2022 | - | $2.48 M(-27.7%) | $10.12 M(-13.0%) |
| June 2022 | $11.63 M(+125.3%) | $3.43 M(+65.1%) | $11.63 M(+8.1%) |
| Mar 2022 | - | $2.08 M(-2.6%) | $10.76 M(+10.9%) |
| Dec 2021 | - | $2.13 M(-46.5%) | $9.70 M(+13.1%) |
| Sept 2021 | - | $3.99 M(+56.2%) | $8.57 M(+66.0%) |
| June 2021 | $5.16 M(+347.3%) | $2.56 M(+151.2%) | $5.16 M(+50.6%) |
| Mar 2021 | - | $1.02 M(+1.0%) | $3.43 M(+36.8%) |
| Dec 2020 | - | $1.01 M(+72.7%) | $2.51 M(+46.8%) |
| Sept 2020 | - | $583.00 K(-28.9%) | $1.71 M(+47.9%) |
| June 2020 | $1.15 M(+16.6%) | $820.00 K(+754.2%) | $1.15 M(+127.6%) |
| Mar 2020 | - | $96.00 K(-53.8%) | $507.00 K(-7.8%) |
| Dec 2019 | - | $208.00 K(+593.3%) | $550.00 K(-24.8%) |
| Sept 2019 | - | $30.00 K(-82.7%) | $731.00 K(-26.2%) |
| June 2019 | $990.00 K(-8.2%) | $173.00 K(+24.5%) | $990.00 K(-9.9%) |
| Mar 2019 | - | $139.00 K(-64.3%) | $1.10 M(-23.9%) |
| Dec 2018 | - | $389.00 K(+34.6%) | $1.45 M(+15.0%) |
| Sept 2018 | - | $289.00 K(+2.5%) | $1.26 M(+16.5%) |
| June 2018 | $1.08 M(-32.3%) | $282.00 K(-41.9%) | $1.08 M(-18.4%) |
| Mar 2018 | - | $485.00 K(+141.3%) | $1.32 M(+16.0%) |
| Dec 2017 | - | $201.00 K(+81.1%) | $1.14 M(+3.4%) |
| Sept 2017 | - | $111.00 K(-78.9%) | $1.10 M(-30.8%) |
| June 2017 | $1.59 M(+2242.6%) | $525.00 K(+73.3%) | $1.59 M(+41.2%) |
| Mar 2017 | - | $303.00 K(+85.9%) | $1.13 M(+36.2%) |
| Dec 2016 | - | $163.00 K(-72.9%) | $828.00 K(+27.0%) |
| Sept 2016 | - | $602.00 K(+903.3%) | $652.00 K(+858.8%) |
| June 2016 | $68.00 K(-68.4%) | $60.00 K(+1900.0%) | $68.00 K(-4.2%) |
| Mar 2016 | - | $3000.00(-123.1%) | $71.00 K(-40.8%) |
| Dec 2015 | - | -$13.00 K(-172.2%) | $120.00 K(-40.6%) |
| Sept 2015 | - | $18.00 K(-71.4%) | $202.00 K(-6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | $215.00 K(-17.0%) | $63.00 K(+21.2%) | $215.00 K(+1.9%) |
| Mar 2015 | - | $52.00 K(-24.6%) | $211.00 K(-23.8%) |
| Dec 2014 | - | $69.00 K(+122.6%) | $277.00 K(+19.9%) |
| Sept 2014 | - | $31.00 K(-47.5%) | $231.00 K(-10.8%) |
| June 2014 | $259.00 K(+32.8%) | $59.00 K(-50.0%) | $259.00 K(+9.3%) |
| Mar 2014 | - | $118.00 K(+413.0%) | $237.00 K(+42.8%) |
| Dec 2013 | - | $23.00 K(-61.0%) | $166.00 K(-15.3%) |
| Sept 2013 | - | $59.00 K(+59.5%) | $196.00 K(+0.5%) |
| June 2013 | $195.00 K(-20.4%) | $37.00 K(-21.3%) | $195.00 K(-10.3%) |
| Mar 2013 | - | $47.00 K(-11.3%) | $217.40 K(-7.1%) |
| Dec 2012 | - | $53.00 K(-8.6%) | $233.90 K(+11.1%) |
| Sept 2012 | - | $58.00 K(-2.4%) | $210.60 K(-14.0%) |
| June 2012 | $245.00 K(+160.4%) | $59.40 K(-6.5%) | $244.90 K(+206.9%) |
| Mar 2012 | - | $63.50 K(+113.8%) | $79.80 K(+13.2%) |
| Dec 2011 | - | $29.70 K(-67.8%) | $70.50 K(-39.5%) |
| Sept 2011 | - | $92.30 K(-187.3%) | $116.50 K(+23.8%) |
| June 2011 | $94.10 K(-83.7%) | -$105.70 K(-295.0%) | $94.10 K(-64.7%) |
| Mar 2011 | - | $54.20 K(-28.4%) | $266.40 K(-28.8%) |
| Dec 2010 | - | $75.70 K(+8.3%) | $374.20 K(-14.4%) |
| Sept 2010 | - | $69.90 K(+5.0%) | $437.00 K(-24.3%) |
| June 2010 | $577.00 K(+1.7%) | $66.60 K(-58.9%) | $577.00 K(-261.1%) |
| Mar 2010 | - | $162.00 K(+17.0%) | -$358.10 K(-23.1%) |
| Dec 2009 | - | $138.50 K(-34.0%) | -$465.70 K(+336.9%) |
| Sept 2009 | - | $209.90 K(-124.2%) | -$106.60 K(-118.8%) |
| June 2009 | $567.30 K(+97.1%) | -$868.50 K(-1696.5%) | $567.40 K(-62.7%) |
| Mar 2009 | - | $54.40 K(-89.1%) | $1.52 M(-6.3%) |
| Dec 2008 | - | $497.60 K(-43.7%) | $1.62 M(+42.0%) |
| Sept 2008 | - | $883.90 K(+939.9%) | $1.14 M(+297.2%) |
| June 2008 | $287.80 K(-64.5%) | $85.00 K(-45.5%) | $287.70 K(+41.9%) |
| Mar 2008 | - | $155.90 K(+770.9%) | $202.70 K(+333.1%) |
| Dec 2007 | - | $17.90 K(-38.1%) | $46.80 K(+61.9%) |
| Sept 2007 | - | $28.90 K | $28.90 K |
| June 2007 | $809.60 K | - | - |
FAQ
- What is iBio annual capital expenditures?
- What is the all time high annual CAPEX for iBio?
- What is iBio annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for iBio?
- What is the all time high TTM CAPEX for iBio?
What is iBio annual capital expenditures?
The current annual CAPEX of IBIO is $210.00 K
What is the all time high annual CAPEX for iBio?
iBio all-time high annual capital expenditures is $11.63 M
What is iBio annual CAPEX year-on-year change?
Over the past year, IBIO annual capital expenditures has changed by -$5.53 M (-96.34%)
What is the all time high quarterly CAPEX for iBio?
iBio all-time high quarterly capital expenditures is $3.99 M
What is the all time high TTM CAPEX for iBio?
iBio all-time high TTM capital expenditures is $11.63 M